Loading company…
Ruojian Huitong develops innovative drugs for ophthalmology.
Founded in 2025 and based in Shenzhen, China, Ruojian Huitong researches and develops ophthalmic drugs. It has two core product pipelines, both described as first-in-class. In March 2025, it raised venture funding from Shenzhen Capital Real Estate Fund and Qianhai Ark Asset Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in